Selective block of delayed rectification (Ik) in feline ventricular myocytes by Wy 48,986, a novel Class III antiarrhythmic agent

Selective block of delayed rectification (Ik) in feline ventricular myocytes by Wy 48,986, a novel Class III antiarrhythmic agent

J Mol Cell Cardiol 21 (Supplement 553 II) (1989) FE Kuhn, RA THE EFFECT OF COCAINE ON THE CANINE CORONARY CIRCULATION. Departments of Medicine and P...

74KB Sizes 0 Downloads 41 Views

J Mol Cell Cardiol 21 (Supplement 553

II) (1989)

FE Kuhn, RA THE EFFECT OF COCAINE ON THE CANINE CORONARY CIRCULATION. Departments of Medicine and Pharmacology, Gillis, R Virmani, GL Schaer. Georgetown University School of Medicine, Washington, DC. The association of cocaine abuse and myocardial infarction led us to study the effect of cocaine (2 mg/kg IV) on hemodynamics, diameter of the left anterior descendins (LAD) coronary artery (auantitative anaiosraohv) and coronary vascular r&.&a&e (CVR,-microsphe&es) in sufenta&il-sedatl ed dogs (n=7). Cocaine produced a 19+3% reduction in LAD diameter (pc.02) This was associated with signifand a-55+20% increase in CVR (pc.05). icant (pc.05) increases in heart rate (7629 to 100+14 beats/min), mean arterial pressure (106+6 to 148+10 mm Hg) and cardiac output (3.7kO.7 to A second group (N=5) was pretreated with the alpha5.421.7 L/min). adrenoceptor antagonist phentolamine (2.5 mg/kg) which prevented cocaine In a third group (n=7) the LAD endoinduced coronary vasoconstriction. thelium was denuded in vivo with an angioplasty balloon prior to cocaine Despite successful denudation, cocaine produced nearly (2 mg/W IV). identical effects on LAD diameter (+19+3%) and CVR (+65-&32%). conclusions: 1) Cocaine produces constriction of epicardial and coronary resistance vessels despite a marked increase in myocardial oxygen demand. 2) These deleterious effects are mediated by alpha-adrenoceptor stimulation and are not potentiated by prior endothelial injury.

554 SELECTIVE

BLOCK OF DELAYED RECTIFICATION (Ik) IN FELINE VENTRICULAR MYOCYTES BY WY 48,986, A NOVEL CLASS III ANTIARRHYTHMIC AGENT. Christopher II. Follmer, Maria T. Poczobutt, Thomas J. Colatsky. Div. of Experimental Therapeutics, Wyeth-Ayerst Research, Princeton, NJ 08543. Wy 48,986 (WY)is an orally active an&rhythmic agentwithClassIIIelectrophysiologicproperties and efficacy against re-entrant arrhythmias. The mechanism by which WY uniformly prolongs cardiac refractory periods was investigated using whole-cell suction pipette voltage clamp techniques on single feline ventricular myocytes. Tail currents elicited upon repolarization from selected test potentials (0 - +60mV, 1 set, Vh=-4OmV, T=32OC) were used to assessblock of the delayed rectifier current Ik. 3pM WY completely blocked tail currents at all test potentials after 30-60 min exposure. Clamp steps to more negative potentials (-100 to -40mV) from a holding potential of -4OmV were used to elicit the inward rectifier current, Ikl. External application of 100 FM WY was required to observe effects on the magnitude and/or kinetics of Ikl. Concentrations as high as 3OOpM had no effect on the inward sodium current (INa) measured under conditions favoring clamp control (T=17uC, reduced Na+ gradient). In conclusion, WYis a potent and selective blocker of the delayed outward potassium current in cardiac tissue,aresultwhichcanexplainthe Class IIIprofile observedinisolated tissues andinvivo.

S.185